Metraipolis › archive › dc_328b59b04ab3

A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease — Europe PMC PMID:42084750

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42084750
DOI
10.1007/s00415-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-02T18:08:33.839Z
SHA-256 of the archived text
cb15ea9849231abdbe490f8d7d6a523355163e694f88bf30061226635f12342e
Stable URL of this page
https://metraipolis.com/documento/dc_328b59b04ab3

How to cite

A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease — Europe PMC PMID:42084750 — Europe PMC (en), https://europepmc.org/article/MED/42084750 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_328b59b04ab3 (Metraipolis archive dc_328b59b04ab3, sha256 cb15ea9849231abdbe490f8d7d6a523355163e694f88bf30061226635f12342e)
BibTeX
@misc{dc328b59b04ab3,
  title = {A new era in neuropharmacology: assessing the efficacy and safety of novel anti-amyloid and non-amyloid drug targets for Alzheimer's disease — Europe PMC PMID:42084750},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42084750},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_328b59b04ab3; sha256 cb15ea9849231abdbe490f8d7d6a523355163e694f88bf30061226635f12342e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42084750. Agents can read the archived copy with the MCP tool read_document.